Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Lawitschka, Anita  [Clear All Filters]
2020
Penack, O., Marchetti, M., Ruutu, T., Aljurf, M., Bacigalupo, A., Bonifazi, F., Ciceri, F., Cornelissen, J., Malladi, R., Duarte, R.F., et al. (2020). Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation.Lancet Haematol7, e157-e167.
2019
Pichler, H., Lawitschka, A., Glogova, E., Willasch, A.M., von Luettichau, I., Lehrnbecher, T., Matthes-Martin, S., Lang, P., Bader, P., Sykora, K.W., et al. (2019). Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia - A prospective international multicenter trial on behalf of the BFM-SG and the EBMT-PDWP.Am J Hematol.
Kuhlen, M., Kunstreich, M., Niinimäki, R., Dunstheimer, D., Lawitschka, A., Bardit, E., Willasch, A., Bader, P., Högler, W., Peters, C., et al. (2019). Guidance to bone morbidity in children and adolescents undergoing allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant.
Schiefer, A.-I., Salzer, E., Füreder, A., Szepfalusi, Z., Müller-Sacherer, T., Huber, W.-D., Michel-Behnke, I., Lawitschka, A., Pichler, H., Mann, G., et al. (2019). PD-L1 and PD1 expression in post-transplantation lymphoproliferative disease (PTLD) of childhood and adolescence: An inter- and intra-individual descriptive study covering the whole spectrum of PTLD categories.Cancer Med.
2016
Schwarz, C., Lawitschka, A., Böhmig, G.A., Dauber, E.M., Greinix, H., Kozakowski, N., Mühlbacher, F., Berlakovich, G.A., and Wekerle, T. (2016). Kidney Transplantation With Corticosteroids Alone After Haploidentical HSCT From The Same Donor.Transplantation.
2013
Geyeregger, R., Freimüller, C., Stevanovic, S., Stemberger, J., Mester, G., Dmytrus, J., Lion, T., Rammensee, H.-G., Fischer, G., Eiz-Vesper, B., et al. (2013). Short-Term In-Vitro Expansion Improves Monitoring and Allows Affordable Generation of Virus-Specific T-Cells against Several Viruses for a Broad Clinical Application.Plos One8, e59592.